Evidence map›Paper›PMID 40433041›Full record

ReviewRSC advances2025

Advancements in silver-based nanocatalysts for organic transformations and other applications: a comprehensive review (2019-2024).

Bhoomi Sachdeva, Nisha, Baby, Khushboo Aggarwal, Aarushi Singh, Kamlesh Kumari, Ramesh Chandra, Snigdha Singh

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bhoomi SachdevaDrug Discovery & Development Laboratory, Department of Chemistry, University of Delhi Delhi-110007 India ssingh3@chemistry.du.ac.in.
NishaDrug Discovery & Development Laboratory, Department of Chemistry, University of Delhi Delhi-110007 India ssingh3@chemistry.du.ac.in.
BabyDrug Discovery & Development Laboratory, Department of Chemistry, University of Delhi Delhi-110007 India ssingh3@chemistry.du.ac.in.
Khushboo AggarwalDrug Discovery & Development Laboratory, Department of Chemistry, University of Delhi Delhi-110007 India ssingh3@chemistry.du.ac.in.
Aarushi SinghDepartment of Chemistry, Ramjas College, University of Delhi Delhi-110007 India.
Kamlesh KumariDepartment of Zoology, University of Delhi Delhi-110007 India.
Ramesh ChandraDr B. R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi Delhi-110007 India.
Snigdha SinghDrug Discovery & Development Laboratory, Department of Chemistry, University of Delhi Delhi-110007 India ssingh3@chemistry.du.ac.in.ORCID https://orcid.org/0000-0003-0319-8887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over time, nanocomposites have revolutionized materials science, offering numerous applications in fields such as catalysis, environmental purification and treatment, biomedicine and various industries. Among these, silver-based nanocomposites are particularly notable for their remarkable stability, reusability, biocompatibility, and multifunctional medicinal properties. Hence, we present a comprehensive summary of recent developments (2019-2024) in silver-based nanomaterials, focusing on their applications across multiple domains, including catalytic organic transformations, biomedical uses, environmental remediation, and industrial sectors such as food packaging, agriculture and textiles. By highlighting recent advancements and emerging trends, we aim to provide a thorough understanding of the role of silver-based nanocomposites in contemporary science and technology, emphasizing their potential to drive innovation across diverse disciplines.

Identifiers

PMID40433041
PMCPMC12107701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.